Skip to main content

Table 4 Percentage of Pax8 positive cases (proportion ≥ 5%)

From: Pax8 as a useful adjunct marker to differentiate pancreatic serous cystadenoma from clear cell renal cell carcinoma in both cytologic and surgical specimens

Pancreatic serous cystadenoma, surgical specimen (n = 23)

0% (0/23)

Pancreatic serous cystadenoma, cytology specimen (n = 10)

0% (0/10)

Metastatic clear cell renal cell carcinoma involving pancreas, cytology specimen (n = 9)

100% (9/9)